InvestorsHub Logo
Followers 2
Posts 392
Boards Moderated 0
Alias Born 04/14/2019

Re: ohm20 post# 44827

Monday, 08/12/2019 7:07:27 AM

Monday, August 12, 2019 7:07:27 AM

Post# of 233200
I understand but resistance takes time to develop

Cytodyn will have to make that first payment to Samsung, which I believe will be due at the end of 2020, and obviously they need the money to continue business. I'm just concerned that cabotegravir approval will seriously eclipse leronlimab.

You and I and those close to Cytodyn can see benefits of leronlimab but I don't think the benefits are nearly extreme enough to make a difference against GSK's sales and marketing onslaught.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News